2015 Q3 Form 10-Q Financial Statement

#000101008615000011 Filed on August 04, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q2 2014 Q2
Revenue $1.300M $1.500M $700.0K
YoY Change 18.18% 114.29% -30.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.321M $2.605M $2.748M
YoY Change -46.2% -5.2% -11.84%
% of Gross Profit
Research & Development $2.427M $2.959M $2.372M
YoY Change -11.49% 24.75% -24.24%
% of Gross Profit
Depreciation & Amortization $52.29K $68.08K $89.69K
YoY Change -40.06% -24.1% -14.28%
% of Gross Profit
Operating Expenses $4.956M $5.800M $5.397M
YoY Change -97.29% 7.47% -18.19%
Operating Profit -$3.629M -$4.332M -$4.747M
YoY Change -98.0% -8.74% -15.73%
Interest Expense $0.00 $13.32K $123.6K
YoY Change -100.0% -89.23% -67.15%
% of Operating Profit
Other Income/Expense, Net $12.48K $10.88K $1.051K
YoY Change 249560.0% 934.92% -23.95%
Pretax Income $5.600M $6.500M -$4.723M
YoY Change -103.07% -237.62% -6.05%
Income Tax $65.91K $88.35K -$1.775M
% Of Pretax Income 1.18% 1.36%
Net Earnings -$5.631M -$6.573M -$2.948M
YoY Change -97.65% 122.96% -3.69%
Net Earnings / Revenue -433.15% -438.2% -421.14%
Basic Earnings Per Share
Diluted Earnings Per Share -$103.9K -$123.1K -$54.31K
COMMON SHARES
Basic Shares Outstanding 53.87M shares 53.50M shares 53.34M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $129.3M $115.7M $99.00M
YoY Change 23.5% 16.87% 200.0%
Cash & Equivalents $129.3M $115.7M $99.03M
Short-Term Investments
Other Short-Term Assets $8.200M $8.000M $13.20M
YoY Change 1071.43% -39.39% -63.23%
Inventory $1.092M $8.770M $16.85M
Prepaid Expenses
Receivables $979.2K $769.2K $742.7K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $139.5M $133.2M $129.7M
YoY Change 12.42% 2.65% -10.9%
LONG-TERM ASSETS
Property, Plant & Equipment $457.5K $446.6K $1.001M
YoY Change -49.91% -55.37% -12.51%
Goodwill $898.3K $898.3K $898.3K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.990M $1.990M $1.999M
YoY Change -0.1% -0.5% -9.21%
Total Long-Term Assets $57.65M $49.29M $79.74M
YoY Change 41.96% -38.18% 153.94%
TOTAL ASSETS
Total Short-Term Assets $139.5M $133.2M $129.7M
Total Long-Term Assets $57.65M $49.29M $79.74M
Total Assets $197.2M $182.5M $209.5M
YoY Change 19.7% -12.89% 18.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.175M $4.781M $1.628M
YoY Change 366.25% 193.61% -89.99%
Accrued Expenses $3.063M $3.243M $4.778M
YoY Change 59.08% -32.12% -13.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $1.979M
YoY Change -100.0% -100.0% -77.91%
Total Short-Term Liabilities $6.238M $8.024M $8.397M
YoY Change 35.87% -4.44% -72.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $997.7K
YoY Change -100.0% -100.0% -66.49%
Other Long-Term Liabilities $448.1M $426.8M $188.5M
YoY Change 15.67% 126.42% 57.48%
Total Long-Term Liabilities $448.1M $426.8M $997.7K
YoY Change 89603.24% 42678.69% -66.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.238M $8.024M $8.397M
Total Long-Term Liabilities $448.1M $426.8M $997.7K
Total Liabilities $461.8M $441.9M $197.9M
YoY Change 17.61% 123.27% 28.84%
SHAREHOLDERS EQUITY
Retained Earnings -$441.3M -$435.7M -$162.9M
YoY Change 9.53% 167.54% 10.57%
Common Stock $176.7M $176.3M $174.4M
YoY Change 0.98% 1.09% 2.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$264.7M -$259.4M $11.57M
YoY Change
Total Liabilities & Shareholders Equity $197.2M $182.5M $209.5M
YoY Change 19.7% -12.89% 18.34%

Cashflow Statement

Concept 2015 Q3 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$5.631M -$6.573M -$2.948M
YoY Change -97.65% 122.96% -3.69%
Depreciation, Depletion And Amortization $52.29K $68.08K $89.69K
YoY Change -40.06% -24.1% -14.28%
Cash From Operating Activities $13.70M $20.10M -$8.070M
YoY Change 35.38% -349.07% -772.5%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K $0.00 -$20.00K
YoY Change -100.0% -77.78%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $530.0K
YoY Change -100.0% -100.0%
Cash From Investing Activities -$60.00K $0.00 $520.0K
YoY Change -98.49% -100.0% -677.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 10.00K -490.0K
YoY Change -100.0% -102.04% -106.84%
NET CHANGE
Cash From Operating Activities 13.70M 20.10M -8.070M
Cash From Investing Activities -60.00K 0.000 520.0K
Cash From Financing Activities 0.000 10.00K -490.0K
Net Change In Cash 13.64M 20.11M -8.040M
YoY Change 141.42% -350.12% -197.22%
FREE CASH FLOW
Cash From Operating Activities $13.70M $20.10M -$8.070M
Capital Expenditures -$60.00K $0.00 -$20.00K
Free Cash Flow $13.76M $20.10M -$8.050M
YoY Change 35.97% -349.69% -724.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
SIGA TECHNOLOGIES INC
dei Trading Symbol
TradingSymbol
SIGAQ
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001010086
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53874294 shares
CY2015Q1 siga Bankruptcyclaimsamountofunliquidatedclaim
Bankruptcyclaimsamountofunliquidatedclaim
109339609 USD
CY2014Q2 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-129398 USD
siga Inventory Write Downs
InventoryWriteDowns
60000 USD
CY2015Q1 siga Finalorderandjudgmentplusinterest
Finalorderandjudgmentplusinterest
195000000 USD
CY2014Q2 siga Proofof Claim Withdrawn
ProofofClaimWithdrawn
971451 USD
CY2015Q2 siga Rent Reduction
RentReduction
35000 USD
CY2015Q2 siga Reorganization Payments
ReorganizationPayments
1700000 USD
siga Reorganization Payments
ReorganizationPayments
2900000 USD
CY2015Q2 siga Reorganization Professional Fees
ReorganizationProfessionalFees
505243 USD
siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
-301893 USD
siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
0 USD
CY2014Q2 siga Inventory Write Downs
InventoryWriteDowns
400000 USD
siga Inventory Write Downs
InventoryWriteDowns
900000 USD
CY2015Q2 siga Inventory Write Downs
InventoryWriteDowns
33000 USD
CY2014Q2 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-145788 USD
siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-301893 USD
CY2014Q3 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-184027 USD
CY2015Q2 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
0 USD
siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
0 USD
CY2014Q3 siga Collateral
Collateral
0.50
CY2014Q4 siga Computer Equipment
ComputerEquipment
669782 USD
CY2015Q2 siga Computer Equipment
ComputerEquipment
669783 USD
siga Courses Delivered Provisional Dosage Twice Daily
CoursesDeliveredProvisionalDosageTwiceDaily
224130 course
CY2015Q1 siga Debt Satisfied
DebtSatisfied
1800000 USD
CY2014Q2 siga Expenseof Warrants Heldas Assets
ExpenseofWarrantsHeldasAssets
34091 USD
CY2015Q2 siga Expenseof Warrants Heldas Assets
ExpenseofWarrantsHeldasAssets
11365 USD
CY2014Q4 siga Liabilitiessubjecttocompromiseaccountspayable
Liabilitiessubjecttocompromiseaccountspayable
3502607 USD
CY2015Q2 siga Liabilitiessubjecttocompromiseaccountspayable
Liabilitiessubjecttocompromiseaccountspayable
826172 USD
CY2014Q4 siga Liabilitiessubjecttocompromisedeferredrevenue
Liabilitiessubjecttocompromisedeferredrevenue
203696194 USD
CY2015Q2 siga Liabilitiessubjecttocompromisedeferredrevenue
Liabilitiessubjecttocompromisedeferredrevenue
0 USD
CY2014Q4 siga Liabilitiessubjecttocompromiselosscontingencylegalfees
Liabilitiessubjecttocompromiselosscontingencylegalfees
3226055 USD
CY2015Q2 siga Liabilitiessubjecttocompromiselosscontingencylegalfees
Liabilitiessubjecttocompromiselosscontingencylegalfees
3226055 USD
CY2014Q4 siga Liabilitiessubjecttocompromiseotheraccruedexpense
Liabilitiessubjecttocompromiseotheraccruedexpense
794750 USD
CY2015Q2 siga Liabilitiessubjecttocompromiseotheraccruedexpense
Liabilitiessubjecttocompromiseotheraccruedexpense
770550 USD
siga Number Of Active Contracts
NumberOfActiveContracts
1 contract
siga Number Of Active Grants
NumberOfActiveGrants
1 grant
CY2014Q2 siga Patent Preparation Fees
PatentPreparationFees
226198 USD
siga Patent Preparation Fees
PatentPreparationFees
511935 USD
CY2015Q2 siga Patent Preparation Fees
PatentPreparationFees
235334 USD
siga Patent Preparation Fees
PatentPreparationFees
568438 USD
CY2015Q2 siga Payment To Post Collateral For Surety Bond
PaymentToPostCollateralForSuretyBond
1300000 USD
CY2015Q2 siga Potential Future Aggregate Research And Development Expenses
PotentialFutureAggregateResearchAndDevelopmentExpenses
8100000 USD
siga Potentialmilestonepayments
Potentialmilestonepayments
5000000 USD
siga Potentialroyalties
Potentialroyalties
0.04
CY2015Q2 siga Prepetition Claim Satisfied
PrepetitionClaimSatisfied
2700000 USD
siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
102035 USD
siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
12200 USD
siga Reorganization Professional Fees
ReorganizationProfessionalFees
1069739 USD
CY2015Q2 siga Reorganization Trusteefees
ReorganizationTrusteefees
13000 USD
siga Reorganization Trusteefees
ReorganizationTrusteefees
26000 USD
CY2014Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
650612 USD
siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1200027 USD
CY2015Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1467460 USD
siga Research And Development Revenue
ResearchAndDevelopmentRevenue
2659551 USD
CY2015Q2 siga Researchand Development Revenue Longterm Contract
ResearchandDevelopmentRevenueLongtermContract
900000 USD
siga Researchand Development Revenue Longterm Contract
ResearchandDevelopmentRevenueLongtermContract
1500000 USD
CY2015Q2 siga Suretybond
Suretybond
2700000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3384310 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4780691 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
491632 USD
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
769214 USD
CY2014Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
17500 USD
CY2015Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
572500 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2085995 USD
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3243021 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
534775 USD
CY2015Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
671646 USD
CY2014Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
271000 USD
CY2015Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
289055 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3497251 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3214742 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
175483180 USD
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
176322914 USD
CY2014Q4 us-gaap Assets
Assets
166385335 USD
CY2015Q2 us-gaap Assets
Assets
182462827 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
129804671 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
133168731 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91309754 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99029327 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99713929 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115656150 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7719573 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15942221 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53504296 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53843044 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53504296 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53843044 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
5351 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
5384 USD
CY2015Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
200000 USD
CY2015Q2 us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
1628603 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4175506 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9627 USD
CY2015Q2 us-gaap Debtor Reorganization Items Other Expense Income
DebtorReorganizationItemsOtherExpenseIncome
3135 USD
us-gaap Debtor Reorganization Items Other Expense Income
DebtorReorganizationItemsOtherExpenseIncome
5672 USD
CY2014Q4 us-gaap Deferred Costs
DeferredCosts
32860874 USD
us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
2830395 USD
CY2015Q2 us-gaap Deferred Costs
DeferredCosts
45959661 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
123609 USD
us-gaap Interest Expense
InterestExpense
264438 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
81799 USD
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
233739966 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5655928 USD
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6819749 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5900468 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7073916 USD
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
89689 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
180804 USD
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68076 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
146854 USD
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
488807 USD
CY2015Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
452696 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
321887 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-238501 USD
CY2014Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2015Q2 us-gaap Goodwill
Goodwill
898334 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
6500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
13600000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4723279 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10346434 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6485089 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13554577 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1775017 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4016312 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
88348 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
172179 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3500667 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2553407 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-239314 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
277582 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
7514381 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
13098787 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
25859668 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
233658167 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3669742 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10273989 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-10546 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-21140 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-33764 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
593310 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
299881 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2355795 USD
CY2015Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7670471 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
19044477 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
13315 USD
us-gaap Interest Expense
InterestExpense
266726 USD
CY2015Q2 us-gaap Inventory Net
InventoryNet
8770488 USD
CY2014Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
16688682 USD
CY2015Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1100017 USD
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3170598 USD
CY2015Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2538844 USD
CY2014Q4 us-gaap Liabilities
Liabilities
412887812 USD
CY2015Q2 us-gaap Liabilities
Liabilities
441852293 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
166385335 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
182462827 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7460253 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8023712 USD
CY2014Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
399039967 USD
CY2015Q2 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
192643138 USD
us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
0 USD
us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
-206396829 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1989948 USD
CY2015Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2014Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
187820361 USD
CY2015Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
187820361 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1313904 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1987800 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
508713 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8524764 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13930021 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-2948262 USD
us-gaap Net Income Loss
NetIncomeLoss
-6330122 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-6573437 USD
us-gaap Net Income Loss
NetIncomeLoss
-13726756 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1051 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1056 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10877 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16341 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
5397121 USD
us-gaap Operating Expenses
OperatingExpenses
11584972 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
5800130 USD
us-gaap Operating Expenses
OperatingExpenses
12031937 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4746509 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10384945 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4332670 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1262720 USD
CY2015Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1709820 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1989520 USD
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1989520 USD
CY2014Q4 us-gaap Other Liabilities
OtherLiabilities
405325 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9372386 USD
CY2015Q2 us-gaap Other Liabilities
OtherLiabilities
371561 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
18150 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
10052 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
415938 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25894 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
898705 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1153130 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
534607 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4329187 USD
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3661323 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
831936 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
446581 USD
CY2014Q2 us-gaap Reorganization Items
ReorganizationItems
0 USD
us-gaap Reorganization Items
ReorganizationItems
0 USD
CY2015Q2 us-gaap Reorganization Items
ReorganizationItems
2149981 USD
us-gaap Reorganization Items
ReorganizationItems
3931806 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000001 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2371869 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5185325 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2959320 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5770501 USD
CY2014Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
4000000 USD
CY2015Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
0 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-421991008 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-435717764 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2799054 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5887712 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2605476 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5692998 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1305446 USD
us-gaap Share Based Compensation
ShareBasedCompensation
873023 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-246502477 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-259389466 USD
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53414296 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53333673 shares
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53589268 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53547017 shares

Files In Submission

Name View Source Status
0001010086-15-000011-index-headers.html Edgar Link pending
0001010086-15-000011-index.html Edgar Link pending
0001010086-15-000011.txt Edgar Link pending
0001010086-15-000011-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20150630.xml Edgar Link completed
siga-20150630.xsd Edgar Link pending
siga-20150630x10q.htm Edgar Link pending
siga-20150630_cal.xml Edgar Link unprocessable
siga-20150630_def.xml Edgar Link unprocessable
siga-20150630_lab.xml Edgar Link unprocessable
siga-20150630_pre.xml Edgar Link unprocessable
siga-exhibit3112015q2.htm Edgar Link pending
siga-exhibit3122015q2.htm Edgar Link pending
siga-exhibit3212015q2.htm Edgar Link pending
siga-exhibit3222015q2.htm Edgar Link pending